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A membrane-inserted structural 
model of the yeast mitofusin Fzo1
Dario De Vecchis1, Laetitia Cavellini2, Marc Baaden  1, Jérôme Hénin  1, Mickaël M. Cohen2 & 
Antoine Taly1
Mitofusins are large transmembrane GTPases of the dynamin-related protein family, and are required 
for the tethering and fusion of mitochondrial outer membranes. Their full-length structures remain 
unknown, which is a limiting factor in the study of outer membrane fusion. We investigated the 
structure and dynamics of the yeast mitofusin Fzo1 through a hybrid computational and experimental 
approach, combining molecular modelling and all-atom molecular dynamics simulations in a lipid 
bilayer with site-directed mutagenesis and in vivo functional assays. The predicted architecture of Fzo1 
improves upon the current domain annotation, with a precise description of the helical spans linked by 
flexible hinges, which are likely of functional significance. In vivo site-directed mutagenesis validates 
salient aspects of this model, notably, the long-distance contacts and residues participating in hinges. 
GDP is predicted to interact with Fzo1 through the G1 and G4 motifs of the GTPase domain. The model 
reveals structural determinants critical for protein function, including regions that may be involved in 
GTPase domain-dependent rearrangements.
The mitochondrial network is in constant motion, and its morphology is determined by the fusion and fission 
of mitochondrial membranes. This process, known as mitochondrial dynamics, is essential for the maintenance, 
function, distribution and inheritance of mitochondria, allowing the cell to respond to its ever-changing physio-
logical conditions1, 2. Defects in mitochondrial dynamics are associated with neurological disorders and plasticity; 
thus, investigations into this subject are physiologically relevant3.
Mitochondria have evolved a set of large GTPases in the dynamin-related protein (DRP) family that consti-
tute the fusion/fission apparatus. Among these DRPs, mitofusins (Mfn1 and Mfn2 in mammals) are dedicated 
to the homotypic tethering and fusion of mitochondrial outer membranes (OMs)4, 5. In addition, Mfn2 is also 
localized on endoplasmic reticulum (ER) membranes to regulate contacts between the ER and mitochondria6–8. 
Fzo1p (hereafter called Fzo1) is the sole mitofusin homologue in Saccharomyces cerevisiae9. Fzo1 is embedded 
in the mitochondrial OM with a transmembrane (TM) region that spans the membrane twice, exposing the 
N- and C-terminal portions to the cytosol and a loop to the intermembrane space10. Fzo1 is characterized by an 
N-terminal GTPase domain flanked by two coiled-coil heptad repeats (HRs) (HRN and HR1, respectively)9, 11. 
The C-terminal region contains an additional HR (HR2).
Although the factors promoting the fusion of mitochondrial membranes were identified more than a decade 
ago, our understanding of the precise sequence of events that lead to the fusion of OMs has long been chal-
lenged by the lack of information regarding mitofusin structures. GTP hydrolysis was recently shown to be 
required to bring the OMs together prior to fusion12, and the integrity of the Fzo1 GTPase domain is essential 
for binding the Mdm30 ubiquitin ligase to the mitofusin13. These observations led to the hypothesis that GTPase 
domain-dependent rearrangements of Fzo1 presumably occur concomitantly with mitochondrial tethering12–15. 
These conformational changes would be comparable to the changes observed in the bacterial dynamin-like pro-
tein (BDLP), a protein related to mitofusins16. The BDLP structure exists in two conformational states: a “closed” 
compact structure observed upon GDP binding16 and an “opened” extended structure observed in the presence 
of a non-hydrolysable GTP analogue17. A similar two-state model may be hypothesized for mitofusins.
The structure of a human Mfn1 fragment (residues 1–364) containing the GTPase domain (residues 75–336) 
linked to the second half of the HR2 domain (residues 694–741) was recently solved and found to exhibit a fold 
that shares a striking similarity to the corresponding regions in BDLP18, 19. This long-awaited observation is not 
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only consistent with the established homology between mitofusins and BDLP but also indicates that molecular 
modelling based on BDLP structures is an effective approach to investigate the architecture of full-length mito-
fusins15, 20, 21. However, previous models of mitofusins were not dynamically assessed in a membrane environment 
and lacked experimental validation.
Here, we present a full-atom homology model of Fzo1 in complex with GDP, which is based on the solved 
crystal structure of BDLP in the closed conformation16. As the proteins are distantly related, the modelling strat-
egy integrated information from several template structures and published experimental data. The proposed 
Fzo1 model was simulated in three extended molecular dynamics (MD) simulations in a fully hydrated lipid 
membrane environment. Model consistency was validated by in vivo experiments using controlled site-directed 
mutagenesis targeting predicted interactions and comparison to partial crystal structures of human Mfn1.
The presented model provides structural insights at the residue level and will be instrumental in shedding light 
on the structural determinants of mitochondrial membrane fusion.
Results and Discussion
A near full-length and consistent mitofusin model based on BDLP. The template search identi-
fied BDLP from Nostoc punctiforme as the most suitable template for homology modelling of S. cerevisiae Fzo1 
(structure 2J68, 3.1 Å16), as it shared 20% sequence identity and 43% similarity with Fzo1 (Supplementary 
Table 1). Several iterations were crucial for improving the stereochemical quality of the model, as shown by steady 
improvements in the stereochemical measures (Table 1).
Percentage of residues within the different Ramachandran plot regions are indicated. The values were deter-
mined using MolProbity22/ProCheck23. The RMSD was computed using UCSF Chimera24 after the superposition 
of the BDLP crystal structure and Fzo1 model for each of the iterations indicated.
Although homologous regions were detected throughout the amino acid sequences of the target and template, 
the N-terminal region showed greater differences between the two species. This divergence is not surprising 
because, unlike other mitofusin family members, Fzo1 possesses a unique heptad repeat (HRN) upstream of the 
GTPase domain2. Furthermore, our analysis using different alignment algorithms showed that the Fzo1 sequence 
aligns well to the template starting at approximately residue 100 (Supplementary Figs 1–4). Secondary struc-
ture predictors (Supplementary Fig. 5) described the region upstream of HRN as unstructured, and the first 86 
N-terminal residues were predicted to be disordered by the DISOPRED3 algorithm25 (Supplementary Fig. 6).
We took advantage of the requirement for Fzo1 during respiration9, 26 to obtain insights into the role of the 
first 86 N-terminal residues upstream of the Fzo1 HRN domain. Thus, we assessed the fermentative (glucose) 
and respiratory (glycerol) growth capacities of three distinct N-terminal deletion mutant strains of FZO1, namely 
fzo1Δ1–30, fzo1Δ1–60 and fzo1Δ1–91 as compared to positive (wild-type) and negative (fzo1Δ) control cells (Fig. 1b). 
Although the fzo1Δ1–30 and fzo1Δ1–60 mutants displayed normal growth on both glucose and glycerol-containing 
media, the respiratory growth of the fzo1Δ1–91 mutant was nearly completely abolished (Fig. 1b). Interestingly, the 
steady-state level of the fzo1Δ1–91 protein was significantly increased compared with that in the wild-type Fzo1 or 
the Fzo1Δ1–30 and Fzo1Δ1–60 mutants (Fig. 1c), suggesting that the deletion of residues 61 to 91 induces stabiliza-
tion of the mitofusin, possibly by inhibiting Mdm30-mediated degradation13. Consistent with this observation, 
Mdm30-mediated ubiquitylation of Fzo1Δ1–91 was undetectable (Fig. 1c). These results indicate that residues 61 
to 91 of Fzo1 are essential for Fzo1 function and its ubiquitin-dependent regulation by Mdm30. These phenotypes 
mimic the previously observed phenotypes following inactivation of the GTPase domain13, suggesting that resi-
dues upstream of the HRN may participate in regulating GTP binding or hydrolysis by the mitofusin.
Despite the previously unappreciated functional importance of residues 61 to 91, the lack of a template for the 
region upstream of the HRN domain and the resulting uncertainty in its structure assignment imposed omitting 
the first 100 amino acids of Fzo1 from the final model. At this stage, we are tempted to speculate that together 
with the N-terminal helix observed in the model presented below (Helix α1 in the HRN), residues 61 to 100 may 
fall back on the GTPase domain to regulate its activity, although further investigation is required.
The Fzo1 model and its essential domains are illustrated in Fig. 1d. Most of the protein is exposed to the cyto-
plasmic side of the lipid bilayer and presents a similar architecture to BDLP, in which the stalk domain is com-
posed of two four-helix bundles connected by hinges16 (Fig. 1d). This organization is consistent with the recently 
solved minimal GTPase domain structures from human mitofusin Mfn1, in which the N- and C-terminal region 
of the GTPase domain form a four-helix bundle together with the HR2 helix that follows hinge 1b18, 19. Since our 
Fzo1 model was built before the partial Mfn1 structures were published, this similarity validates the homologous 
regions in our model and provides substantial confidence in domains of the molecule that are not present in the 
Mfn1 fragment (e.g., the TM region, the trunk and hinges 1a/1b).
First 
alignment
Manually refined 
alignment
Loop modelling and 
structural refinement
% Most 
favoured 89/83.9 93/90.9 93.8/90.9
% Additional 
allowed 7.9/14.9 4.3/7.8 6.2/8.9
% Outliers 3.1/1.3 2.7/1.3 0/0.2
RMSD (Å) 0.9 0.7 0.6
Table 1. Stereochemical evaluation of the Fzo1 model during the modelling procedure.
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The Fzo1 model has a stable core when simulated in a membrane environment. The conforma-
tional stability of the Fzo1 model was assessed in three 500-ns MD trajectories in a mixed lipid bilayer environ-
ment (referred to as Fzo1.I, Fzo1.II and Fzo1.III).
The predominant secondary structure of the Fzo1 model confirms a coherent and stable architecture between 
the three simulations (Fig. 2), with a clear pattern of long α-helices retained during the time course of the simula-
tion, notably for the predicted coiled-coil domains HRN, HR1 and HR2, as well as for the TM dimer.
Supplementary Fig. 7 and Supplementary Table 2 show the drift of the protein structure from the 
energy-minimized initial model as time series of the RMSD. The high RMSD values observed for the whole 
protein in the last frame (5.7–7.3 Å) account for significant local structural deviations (Supplementary Fig. 7, 
top panels, black lines). The decomposition into protein segments (Supplementary Fig. 7, top panels) reveals 
that these high values are mostly due to i) unstructured regions, ii) portions of the structure that possess high 
flexibility, such as the N-terminal helices, as measured by the RMSF (Supplementary Fig. 7, top panels, red lines), 
and iii) regions that are unresolved in the template crystal structure, i.e., residues 502–510 (residues 631–653 in 
the Fzo1 model). When the contribution of these components is removed, a lower RMSD with a plateau between 
4–5 Å is observed (Supplementary Fig. 7, top panels). The analysis of the ab initio modelled TM domain shows 
the same average RMSD value of 2.4 Å (Supplementary Table 3), indicating stability and consistency among the 
three trajectories.
Figure 1. Architecture and domain organization of the Fzo1 model. (a) Scheme showing the domains of Fzo1 
from S. cerevisiae. Residue numbers for each domain and the deletion mutants are indicated. The red arrow 
highlights the deletion mutant that causes a defect in respiration. HRN, N-terminal truncated heptad repeat 
(violet, residues 101–190); GTPase, GTPase domain (red, residues 194–373); HR1, heptad repeat 1 (green, 
residues 484–547); transmembrane segments (yellow, residues 706–757), HR2, heptad repeat 2 (orange, residues 
769–831). The fragments between the hinges are indicated below the alignment and are designated A to E. 
(b) Dextrose and glycerol growth spot assay for the 30-, 60- and 91-amino acid N-terminal FZO1 deletion 
mutant strains, namely fzo1Δ1–30, fzo1Δ1–60 and fzo1Δ1–91, respectively. The fzo1Δ and FZO1-Myc strains were 
used as negative and positive controls, respectively. (c) Anti-Myc and Anti-Pgk1 immunoblots of whole-cell 
extracts prepared from the strains used in (b). The FZO1-Myc mdm30Δ strain was used as a control for lack 
of Fzo1 ubiquitylation. Molecular weight markers are indicated on the right of long or short exposures of the 
immunoblots. (d) Fzo1 model after the equilibration phase (as described in the Methods section). The blue 
surface represents POPE and POPC lipids from a portion of the bilayer. The GDP nucleotide and the Mg2+ ion 
are depicted in the space-filled representation.
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Together, these results indicate consistency among the trajectories that show a similar fluctuation profile 
(Supplementary Fig. 6) with the model that underwent the equilibration and production stages, maintaining the 
proposed fold.
Fzo1 transmembrane domain. The highest-scoring model constructed using PREDDIMER27 shows a compact 
structure characterized by a crossing angle (χ) of 119.7° (other models are shown in Supplementary Fig. 8). 
The second TM helix (TM2) harbours a GxxxG motif (with x representing any amino acid) that was previously 
reported to play a role in helix dimerization28, 29. We based our choice on the observation that interactions with 
(small)xxx(small) motifs are often associated with the formation of right-handed dimers characterized by neg-
ative helix-helix crossing-angles in parallel dimers30–32. Here we have a right-handed antiparallel dimer, with 
χ = 120° (Supplementary Fig. 8). This is currently the most plausible arrangement. The second-highest scor-
ing model has a similar score and involves the same dimerization motif, although with a straighter geometry 
(χ = 175°, nearly antiparallel). While the latter arrangement is less common it cannot be excluded and the reader 
should be aware that alternative transmembrane arrangements are possible.
According to the RMSD analysis for each MD simulation trajectory (Supplementary Fig. 7), the TM domain 
is well anchored and does not undergo notable structural changes, as confirmed by the analysis of the dominant 
secondary structure (Fig. 2). The observed fluctuation values are similar in the three replicates (Supplementary 
Fig. 6). These features suggest that the structure of the TM domain is realistic.
To characterize the interaction between the two TMDs in more details than just pure geometrical contacts, we 
analysed specific hydrogens bonds as described in methods. All simulations indicated a hydrogen bond between 
the two TM helices that involved the side-chains of Lys716 and Ser746 (38%, 19% and 18% persistence for Fzo1.I, 
Fzo1.II and Fzo1.III, respectively). Notably, Ser746 resides on the TM2 helix and belongs to the aforementioned 
GxxxG motif.
Analysis of the contact residues in the TM dimer revealed an abundance of promiscuous stabilizing inter-
actions (Supplementary Table 4). The only unambiguous interaction seemed to be Phe711-Ile753, whereas the 
remainder of the interactions varied among the trajectories. After manually adjusting the side-chain rotamer (see 
Methods), the Ile753 residue on helix TM1 directly faced residue Phe711 on TM2, increasing the packing of the 
TM helices (Fig. 3b). The analysis of protein-lipid hydrogen-bonding indicated that Fzo1 had more interactions 
with POPE compared to POPC (Supplementary Table 5). Given that the bilayer contains both lipids in the same 
proportion, this observation suggests a preference for POPE.
Experimental validation of the Fzo1 model. The yeast mitofusin Fzo1 has previously been character-
ized by introducing many mutations across its functional domains (Supplementary Fig. 9). We aimed to evaluate 
the relationship between our structural model and the wealth of published data available, as well as the additional 
targeted mutations summarized in Supplementary Table 6 and discussed hereafter. This analysis was performed 
on the most representative structure (i.e., a centroid) identified after a cluster analysis of the Fzo1.I trajectory (see 
the Methods).
Figure 4 shows the secondary structure elements. The organization of the HR domains in our model reveals a 
more complex organization than initially hypothesized, as these repeats are not merely assembled as continuous 
helices. In particular, HRN, HR1 and HR2 are characterized by a complex structure and are composed of several 
tandem helices. This observation may be key to interpreting the functional outcomes of several Fzo1 mutations. 
For instance, according to our model, previously uncharacterized regions, such as the α14 and α27 helices, may 
contribute to protein function. Although these helices are not defined by any heptad periodicity, they represent 
a structural continuation of the HR1 and HR2 repeats, separated by the hinges 1a and 1b, respectively (Fig. 4, 
blue arrows). Consequently, helices α14 and α27 are located parallel to the HRN in our 3D model (Fig. 1d). This 
configuration is strikingly similar to the four-helix bundle observed in the recent crystal structure of an Mfn1 
fragment (Supplementary Fig. 10), in which the C-terminal helix has been proposed to stabilize the identified 
bundle18. Here, we propose that Fzo1 helix α27 (Fig. 4) plays a similar role (Supplementary Fig. 10). Consistent 
with this observation, deletion of the last 24 residues of Fzo1 (Fzo1 ∆826–855) was previously shown to abolish 
mitochondrial fusion34. Although the reconstitution of helix α27 in our model (res 815–845) results from the 
manual modification of the target-template alignment (see Methods), the considerations described above provide 
a significant validation of our modelling approach.
Based on these observations, we refined our analysis of the model using a series of site-directed mutagenesis 
experiments across the predicted interactions revealed during the MD analysis.
Figure 2. Stable secondary structure motifs in simulations. Comparison of the Fzo1 domain organization 
shown in Fig. 1a with the stable secondary structures (persistence greater than 90%) in the three replicate 
simulations. The colour code is blue, α-helix; red, β-sheet; yellow, turn; green, bend; black, β-bridge; and violet, 
π-helix.
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Interactions between the N- and C-terminal halves of the protein. We searched for salt bridges to test experi-
mentally the putative interactions and validate the proposed model for Fzo1. We focused our attention on the 
predicted salt bridge D335-K464 (Fig. 5) because the interaction was identified in the model after the minimiza-
tion phase and is conserved in BDLP, where both charged residues are inverted (His202 and Glu331, respectively, 
Figure 3. Insights into the Fzo1 transmembrane domain. (a) PREDDIMER27 ab initio prediction of the helical 
dimer (FSCOR 3.113, crossing angle χ 119.7°). (b,c) Snapshots from the Fzo1.I trajectory showing the most 
representative structure (i.e., the centroid). Glycine residues within the GxxxG motif are presented as a space-
filled representation, whereas residues involved in interactions are depicted in stick form. Phosphate atoms from 
POPC and POPE (orange) and water molecules (cyan) are indicated, whereas the rest of the protein is omitted 
for clarity.
Figure 4. Cartoon representation of the Fzo1 model and its functional domains. (top) Residue numbers 
delimiting the domains, (bottom) secondary structure elements are annotated with the Fzo1 mutations 
performed in this study. Mutants considered for the charge swap strategy are connected by a bar. The colour 
code is cyan, loss of function (LOF) and maroon, wild-type phenotypes. Putative hinge regions are indicated by 
blue arrows. Previously reported mutations across Fzo1 functional domains are shown in Supplementary Fig. 9. 
Green and pink horizontal bars above the secondary structure elements depict the N- and C-terminal halves, 
respectively. The topology diagram was generated using the HERA tool33.
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Supplementary Fig. 11). We maintained the focus on D335-K464, even though the interaction was weakened in 
subsequent simulations (1.5%, 2% and 27% for Fzo1.I, Fzo1.II and Fzo1.III, respectively). This choice was moti-
vated by the following observations: a preliminary MD study suggested that the salt bridge was present in 61% 
of structures, and the solved fragment from Mfn1 shows an interaction between the homologous pair of charged 
residues, Asp200 and Lys33618, 19 (Supplementary Fig. 10). In addition, these mutants provide us with the oppor-
tunity to investigate the importance of the Lys464 residue, which is a target for post-translational modification 
by ubiquitin in Fzo115.
We employed a charge swap strategy to assess this predicted interaction, which relies on the assumption that 
a double charge reversal mutation across a predicted salt bridge should restore a wild-type phenotype, whereas 
Figure 5. Swap mutations across the predicted salt bridge D335-K464. (a) Relative positions of D335 (red) 
and K464 (blue) in the Fzo1 model. The green and pink regions correspond to the N- and C-terminal halves, 
respectively (Supplementary Fig. 9). (b) Dextrose and glycerol growth spot assay. (c) Anti-Fzo1 and anti-Pgk1 
immunoblots of whole-cell extracts prepared from the strains analysed in (b). Molecular weight markers 
are indicated on the right. (d) Anti-Myc and Anti-Pgk1 immunoblots of whole-cell extracts prepared from 
the indicated strains. Molecular weight markers are indicated on the right of long or short exposures of the 
immunoblots.
www.nature.com/scientificreports/
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single point mutations may abolish the salt bridge, therefore affecting protein function. Although the single point 
mutations D335K and K464D induced a total inhibition of respiratory growth, this strong defect was partially but 
significantly corrected by the swap mutation D335K-K464D (Fig. 5b), thus confirming the proximity between 
residues at position 335 and 464. Consistent with the role of K464 in the ubiquitin-mediated degradation of 
Fzo115, the level of the Fzo1 K464D mutant protein increased compared with that of the wild-type control. Both 
the Fzo1 D335K single mutant and, most surprisingly, the D335K-K464D double mutant (charge swap) displayed 
levels comparable to the wild-type protein. This observation led to compare the ubiquitylation status of single 
(K464D) or double swap (D335K-K464D) Fzo1-13Myc mutants with that of K398R that is established to alter 
ubiquitylation of the mitofusin15, 35. As expected, detection of the Mdm30-dependent ubiquitylation doublet 
was strongly impaired in K464D and K398R mutants (Fig. 5d). Strikingly, however, the double swap mutation 
D335K-K464D restored partial ubiquitylation of Fzo1-13Myc (Fig. 5d). As aspartate cannot be ubiquitylated, the 
swap mutations may thus also allow position 335 to be ubiquitylated by restoring the proximity of residues 335 
and 464. Alternatively, this restored proximity may contribute to maintain a correct fold of Fzo1 that would favor 
ubiquitylation on K398. The latter possibility is more likely as K398 is the main target for Mdm30-dependent 
ubiquitylation of Fzo135. In aggregate, these results provide experimental confirmation of a physical interaction 
between the two residues located in the N- and C-terminal halves of Fzo1 and contribute to validating the pre-
dicted proximity in our model.
In order to further cross-validate our model, we have constructed a new partial Fzo1 model based on human 
Mfn1 crystal19 (Supplementary Fig. 10). We compared key interactions predicted by our BDLP-based model with 
the alternative partial model. Interestingly, among the numerous interactions conserved (Supplementary Fig. 10), 
the predicted interaction between K464 and D355 (Fig. 5), is also observed in the Mfn1-based model.
Electrostatic interactions are involved in organizing the HR domain. The HR regions in Fzo1 are required for 
mitofusin architecture, showing LOF phenotypes upon disruption of their presumed helical folds imposed by 
proline mutations11. In our model, the coiled-coil HR1 and HR2 domains form an antiparallel bundle (Fig. 1d). 
Yet surprisingly, we did not observe the typical HR interaction pattern in the HR1/HR2 coiled-coil structure 
(Supplementary Table 7 and Supplementary Fig. 12). The hydrophobic spine of HR2 is solvent-exposed, and the 
HR1 hydrophobic spine actively interacts with the nearby α18 helix (residues 584–630, Fig. 4 and Supplementary 
Fig. 12), which interestingly does not exhibit heptad periodicity. Consequently, the HR2 repeat may be available 
for putative interactions between Fzo1 molecules similarly to human Mfn1, in which the HR2 domain dimerize 
through anti-parallel binding36. Whether these interactions take place in trans (between Fzo1 molecules from 
opposing membranes) as previously proposed20, 36 or in cis (between Fzo1 molecules from the same membranes) 
prior to mitochondrial tethering37 is an important question that will need future clarification.
In contrast to the lack of a classical pattern of hydrophobic interactions, we observed a network of intra- and 
interhelical salt bridges in the simulations. According the convention of labelling residues in a heptad repeat 
from a to g, with a and d usually indicating hydrophobic residues38, intrahelical interactions were observed in 
all three domains, with the majority of the b-e type, similar to the pattern previously observed for the neuronal 
SNARE complex39. Almost all interhelical salt bridges connected HR1 and HR2, with one exception connecting 
HRN and HR2 (observed only in Fzo1.II). The 8 salt bridges that persisted in all three trajectories are listed 
in Supplementary Table 8. We used site-directed mutagenesis to investigate a possible interhelical salt bridge 
between the HR1 and HR2 domains, the D523-H780 salt bridge, which was identified early on as having high 
persistence in a preliminary simulation. Indeed, although the distance rapidly rises above the adopted interaction 
cut-off of 6.5 Angstrom, the distance between its charged groups remains constant below 10 Å during the sim-
ulation. The charge swap strategy applied to these two residues revealed that the D523H point mutation caused 
a temperature-dependent respiratory growth defect. However, the H780D mutant yields a wild-type phenotype 
(Fig. 6b). Although this result may seem difficult to rationalize, an interpretation based on common observations 
with charge reversal mutations is that D523 and/or D780 may interact with more than one partner, allowing 
for a form of compensation when H780 is mutated. Strikingly, the swap mutant D523H-H780D induced com-
plete rescue of the respiration defect caused by the D523H mutation. This result is consistent with the proximity 
between HR1 and HR2 in the Fzo1 model and suggests that this proximity is a requirement for mitofusin activ-
ity. Although the predicted salt bridge D523-H780 (HR1 and HR2, respectively) shown in Fig. 6 is not directly 
conserved, it is located near a salt bridge identified in the template structure of BDLP (D523 and H780 in Fzo1 
correspond to I390 and F624 in BDLP, next to bridging residues R393 and D625; see the sequence alignment in 
Supplementary Fig. 11).
A recent study hypothesized that the HR2 domain may dissociate from the HR1 domain in active forms of 
Mfn2 and unfold itself from the rest of the protein to become available for trans interactions with exposed HR2 
domains of Mfn2 molecules from opposing mitochondria20. However, a dissociation of one of the repeats seems 
unlikely because our model features tight interactions between the coiled-coil HR1 and HR2 domains, which 
appear to be required for maintaining the mitofusin fold (Fig. 1d).
Functional importance of the regions surrounding hinges 1a and 1b in the Fzo1 model. A tempting alternative 
hypothesis to the mitofusin conformational switch mediated by HR2 extension is the possibility that mitofusins 
perform extensive GTPase domain-dependent rearrangements through hinges 1a and 1b (Fig. 4), similar to 
BDLP17. In this regard, Mdm30 was previously shown to bind the N-terminal half of Fzo1 (HRN/GTPase domain) 
in a manner that required the GTPase domain-dependent displacement of the C-terminal half (HR1/TM/HR2 
domain)13. Mutations within the HR2 domain that disrupt the interaction between the N- and C-terminal halves 
of Fzo111 were thus expected to promote constitutive Mdm30 binding. Consistent with this hypothesis, the L819P 
mutation induced an increase in Mdm30-dependent ubiquitylation of Fzo1 and markedly accelerated the degra-
dation of the mitofusin13.
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The Leu819 residue is located on helix α27 of the Fzo1 model, with its side chain facing the helix α14 (Fig. 7a). 
Consistent with this arrangement, introduction of a negative charge at position 819 (L819E) impaired respiratory 
growth at 30 and 37 °C whereas replacement with an uncharged residue (L819A) did not have any effect (Fig. 7b). 
As previously shown, the L819P mutation abolished respiration at all temperatures (Fig. 7b) and enhanced degra-
dation of Fzo1 (Fig. 7f). The location of Leu819 in hinge 1b suggests that the L819P mutation may induce a kink 
in this region that would in turn favor a conformational rearrangement of the mitofusin. To explore this possibil-
ity, we reasoned that perturbing the backbone conformation around Leu819 should also promote conformational 
remodelling of Fzo1 and mimic the L819P mutation effect. In this regard, Glu818 is predicted to lie in hinge 1b, 
with a water-exposed side-chain. Removing the side-chain charge (E818A) or even reversing it (E818R) did not 
affect respiratory growth, indicating that this position is not sensitive to modifications of the side-chain. However, 
we confirmed that this position is sensitive to backbone effects by introducing a proline residue (E818P) that 
completely abolished yeast growth on glycerol media (Fig. 7c). Moreover, while the E818P mutation induced an 
Fzo1 decrease that does not depend on Mdm30 (Fig. 7d; compare lanes 2 and 4), this mutant was also degraded 
by the Mdm30-mediated pathway twice more than wild-type Fzo1 (graph Fig. 7d). This observation is consistent 
with the effects of L819P and the potential conformational switch it exerts on Fzo1.
Tyr490 is located in hinge 1a in our model and is predicted to interact with Leu819 in Fzo1.I and Fzo1.II 
(75% and 61%, respectively) (Fig. 7a). Similar to L819A but in contrast to L819E, mutation of Tyr490 in Alanine 
(Y490A) or Lysine (Y490K) did not affect respiratory growth (Fig. 7e). However, combining Y490K with L819E 
Figure 6. Swap mutations across the predicted salt bridge D523-H780. (a) Location of D523 (red) and H780 
(blue) in the Fzo1 model. The green and pink regions correspond to the N- and C-terminal halves, respectively 
(Supplementary Fig. 9). The positions of HR1 and HR2 are indicated. (b) Dextrose and glycerol growth spot 
assay. (c) Immunoblots of whole-cell extracts prepared from the strains analysed in (b). The Pgk1 immunoblot 
was used as a loading control. Molecular weight markers are indicated on the right.
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(Y490K-L819E) induced an enhanced defect in respiration as compared to L819E (Fig. 7e) without affecting Fzo1 
levels (Fig. 7f). This confirms the predicted proximity between Tyr490 and Leu819. Moreover, the Y490P muta-
tion was previously reported to cause total inhibition of respiratory growth and induce the formation of loose 
mitochondrial aggregates that were hypothesized to result from a tethered trapping state11. Similar to hinge 1b, a 
mutation of Tyr490 to proline within hinge 1a may thus affect mitochondrial fusion by inducing conformational 
rearrangements in Fzo1.
Single point mutations, L501A and L504A, of residues located on the other side of the hinge were previously 
shown to be functionally silent but abolished mitochondrial fusion in combination11. Thus, these mutations were 
hypothesized to affect hydrophobic interactions, as both leucines were predicted to occupy the a and d positions 
in the HR1 domain11. The analysis of the contacts within our model revealed that these two leucine residues may 
in fact belong to a leucine cluster between residues Leu501, Leu504 and Leu802, which is located in close vicinity 
to hinge 1b (Fig. 7a). This cluster may explain the differential phenotypes obtained with the L501A or L504A 
mutants, as Leu802 may compensate for the single mutation but not the double point mutations.
Figure 7. Critical residues in the Fzo1 model hinge region. (a) Detailed structure of the putative hinge region. 
The colour code is: cyan: Leu819, yellow: Tyr490, purple: Leu802, red: Glu818, grey: Leu501, and light grey: 
Leu504. The domains are: violet: HRN, green: HR1, and orange: HR2. The location of this hinge region within 
the model is presented in the right panel. (b), (c) and (e) Dextrose and glycerol growth spot assay with indicated 
strains. (d) and (f) Anti-Fzo1 and anti-Pgk1 immunoblots of whole-cell extracts prepared from the strains 
used in (b), (c) and (e). Molecular weight markers are indicated on the right of immunoblots. The graph in (d) 
represents the quantified ratio of Mdm30-dependent degradation for wild-type Fzo1 or the Fzo1 E818P mutant.
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Thus, these results highlight the critical importance of regions surrounding hinges 1a and 1b in Fzo1 function 
and suggest that they may be involved in mitofusin rearrangements.
Atomistic insights into the GTPase domain. Binding site architecture and protein-GDP interac-
tions. Protein-GDP interactions were modelled based on the homologous interacting residues in the BDLP 
template. Ten H-bonds were identified in the BDLP structure (Supplementary Table 9). The 10 corresponding 
donor-acceptor distances were restrained during the modelling procedure and the equilibration phase (Fig. 8 
and methods for details). The time series of these distances in the three simulations were monitored during the 
equilibration phase and for each trajectory (Fig. 8 right and Supplementary Fig. 13).
The residues forming persistent, tight contacts were Asn197, Ser201 and Ala202. Contacts showing more 
variation after the restrained equilibration phase were formed by Thr198, Lys370, Lys371 and Asp373. Contacts 
Figure 8. Analysis of the key protein-GDP interactions in the Fzo1 nucleotide-binding site. The colour code 
is grey during the equilibration phase, cyan for simulation Fzo1.I, green for Fzo1.II and purple for Fzo1.III. 
Distance restraints and persistent H-bonds over 50% of the simulation time are indicated with orange and green 
dotted lines, respectively. The G-boxes from G1 to G4 are highlighted. The evolution of the donor-acceptor 
distance network for the residues contacting the ligand is presented on the right. The last three blocks show the 
new interactions observed in Fzo1 with respect to BDLP, and the red line delimits the end of the equilibration 
phase. Donor-acceptor distances are depicted using a colour gradient from the darkest (below or equal to 3.5 Å) 
to lightest colours (up to 4.0 Å).
www.nature.com/scientificreports/
1 1SCIentIfIC REPORTS | 7: 10217  | DOI:10.1038/s41598-017-10687-2
involving Asp428 and Gly427 were predicted based on the template but were not retained in the unrestrained 
trajectories. An equivalent network involving the homologous residues N237 (Fzo1-K370), D240 (Fzo1-D373) 
and others (Supplementary Table 10) was found in the recent crystal structures from human Mfn118, 19, and is 
conserved in our Mfn1-based model (Supplementary Fig. 10). Our approach thus provides insight into the resi-
dues that promote the stabilization of the nucleotide within the Fzo1 GTPase domain.
MD simulations further revealed new interactions in the Fzo1 model. In particular, His426 contacted the 
GDP.N1 in Fzo1.I after the displacement of the Asp428 residue (Fig. 8 right). Furthermore, the Gly199 residue 
contacted the bridging oxygen between the two phosphates (GDP.O3A), and the Glu215 residue was involved in 
an interaction, characterized by a 46% persistence in Fzo1.III, with the ribose in position O2′ oriented towards 
the backbone (Fig. 8 left). Our model also includes a magnesium ion in the nucleotide binding site, which partic-
ipates in coordinating GDP with the Ser201 residue (see Supplementary Fig. 14), similar to human dynamin or 
atlastin40, 41. This feature is not only in agreement with the structure of the human Mfn1 fragment in which the 
Ser89 residue directly coordinates a bound magnesium ion19 but is also consistent with the requirement for this 
ion in the tethering of proteoliposomes by the Mfn1 construct18.
GDP primarily interacts with the G1 and G4 motifs. In particular, G1 (the P-loop) anchors both phosphate 
groups (Fig. 8 left). The G2 (switch I) and G3 motifs point away from the active site, suggesting a more structural 
role. This observation is consistent with the orientation of Thr103 in the BDLP crystal structure away from the 
active site16 and the critical role of the corresponding conserved Thr221 (i.e., G2 motif) in Fzo1 function9, 11, 13. 
These properties are typical of GTPase domains41, 42.
A positive charge at position 200 is essential for GTPase domain integrity. The vicinity between the residues of 
the GTPase binding site in the model features a high confidence salt bridge that connects the G1 (Lys200) and 
G3 motifs (Asp313). This salt bridge is not only conserved in BDLP (Lys82 and Asp180, respectively) but also 
detected in all three MD replicates, Fzo1.I, Fzo1.II and Fzo1.III, with a persistence greater than 90%. Surprisingly, 
the charge swap strategy applied to this predicted salt bridge revealed that although the single mutations K200D 
and D313K induced an expected and strong inhibition of respiratory growth, the double K200D-D313K mutation 
(charge swap) did not rescue this defect (Fig. 9b).
Figure 9. Swap mutations across the predicted salt bridge K200-D313. (a) Location of D313 (red) and K200 
(blue) in the Fzo1 model. The most representative structure after the cluster analysis on the Fzo1.I trajectory is 
shown (i.e., the centroid). The green and pink regions correspond to the N- and C-terminal halves, respectively 
(Supplementary Fig. 9). The GDP atoms and the bound magnesium are indicated. (b) Dextrose and glycerol 
growth spot assay. Single mutations across the predicted interaction cause a severe respiration defect, and the 
double mutant (charge swap) does not rescue these defects. (c) Dextrose and glycerol growth spot assay. The 
K200A and K200D point mutations affect respiration, whereas the K200R mutation does not impact growth 
on glycerol media. (d) Anti-Fzo1 immunoblot of whole-cell extracts prepared from the strains used in (c). The 
Pgk1 immunoblot was used as a loading control. Molecular weight markers are indicated on the right.
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The conserved lysine in the G1 motif has been widely studied using alanine/threonine mutants and has been 
classified as essential for mitofusin5, 9, 11, 43 and BDLP function16. In addition, the K200A mutant abrogates the 
Mdm30-dependent degradation of Fzo1 in yeast13. More recently, the K88A mutation of the corresponding 
lysine residue in Mfn1 was shown to promote the coordination of the γ-phosphate of GTP by Lys99, thereby 
inducing the drastic bending of GTP and the inhibition of hydrolysis18 (Supplementary Fig. 10). Moreover, the 
homologous position in human dynamin (Lys44) was proposed to counteract the developing negative charge 
of the γ-phosphate group that is released during GTP hydrolysis41. Thus, we reasoned that the positive charge 
provided by the lysine at position 200 may be essential for GTP hydrolysis, which could explain the failure of 
the K200D-D313K swap mutation to restore functional mitochondrial fusion. Furthermore, a negative charge at 
position 200 may weaken (if not abolish) the interaction with the nearby negatively charged nucleotide.
We introduced a conservative charged mutation to arginine at position 200 (K200R) and compared the effects 
of the K200A, K200D and K200R mutations on respiratory growth to test this hypothesis. Remarkably, although 
K200D abolished growth on glycerol media and K200A induced strong thermosensitive defects, K200R main-
tained full respiratory growth capacity at all tested temperatures (Fig. 9c). Consistent with this observation, the 
Mdm30-mediated degradation, and thus the GTPase domain integrity13, were affected in Fzo1 K200A and Fzo1 
K200D but not Fzo1 K200R (Fig. 9d). Therefore, a positive charge in position 200 is required for Fzo1 function. 
This finding explains the failure of the D313K-K200D charge swap mutant to rescue respiratory growth but also 
suggests that the positive charge at position 200 participates in GTP hydrolysis.
Conclusions
Using the homology modelling approach based on the structure of the bacterial dynamin BDLP, we have mod-
elled the structure of the Fzo1 mitofusin in complex with the nucleotide GDP. The structural model is stable under 
simulation, experimentally validated in vivo and consistent with published data. The model provides insights at 
the residue level and describes Fzo1 as being partitioned into distinct structural regions: the GTPase domain, a 
four-helix bundle, a hinge region, and a three-helix trunk connected to the TM domain. Little is known about the 
precise sequence of events that may couple GTP hydrolysis to potential conformational rearrangements within 
mitofusins. In this regard, the conserved four-helix bundle observed in the Mfn1 partial structures18, 19 and in 
our full-length Fzo1 model is reminiscent of the characteristic bundle signalling element (BSE) of dynamins41, 42. 
The BSE domain has been proposed to transfer conformational information from the GTPase domain to the 
trunk region of dynamin during membrane fission catalysis41. Considering the continuity between the four-helix 
bundle and the putative hinge region in Fzo1 (Supplementary Fig. 10), this structural motif may play a similar 
role during membrane fusion. When comparing the Mfn1- and the BDLP-based models we have constructed, the 
bundles are arranged differently (Supplementary Fig. 10). While this difference may involve the artificial linker 
that allowed obtaining the Mfn1 crystals18, 19, our BDLP-based model suggests that the bundle likely adopts a 
distinct conformation that could provide optimal flexibility in the hinge 1a/1b regions, which warrants further 
insights on the structure of full-length mitofusins. Mitofusins do not function as monomers but oligomerize in 
both cis (on the same lipid bilayer) and trans (from opposing lipid bilayers) to mediate membrane attachment and 
fusion4, 11, 19, 36, 37, 44. As the precise principles for these oligomerization properties emerge, future studies should 
aim to model these complexes in presumably “active” and “inactive” conformations and thereby further elucidate 
the precise events that lead to mitofusin-mediated membrane fusion.
Materials and Methods
Bioinformatic analysis. Sequences identification and alignments. The S. cerevisiae Fzo1 target sequence 
was obtained from the UniProtKB database (Universal Protein Resource Knowledgebase45), entry: P38297. A 
putative template was identified using the BLASTP tool (Basic Local Alignment Search Tool for proteins46) against 
the PDB (Protein Data Bank47, with default settings. Homologues for the template in the phylum Cyanobacteria 
were then selected using the BLAST method (with default settings), from which a set of 43 sequences annotated as 
dynamin-like proteins was selected. The identity ranged from 22% to 87%, and the sequence coverage was greater 
than 65%. This set was then aligned with Expresso48 using structural information from the template structure with 
PDB-id 2J6816. After removing the first 100 N-terminal residues of Fzo1, we merged the multiple sequence align-
ment (MSA) described above with the target sequence using M-Coffee49. We used NCBI HomoloGene (https://
www.ncbi.nlm.nih.gov/homologene, accessed 10-05-2016) to add a restricted set of 11 homologous sequences 
belonging to the families of fuzzy onions (FZO1), FZO-like (FZL), mitofusin (MFN1 and MFN2) (hgid: 31469, 
95893, 11481 and 8915, respectively), which are listed in Supplementary Table 1.
Supplemental alignments were constructed to identify the target-template correlation in the N-terminal 
region. Two different alignment algorithms, Clustal Omega50 and T-Coffee51, were chosen to combine the set of 
43 homologous template sequences. Then, the resulting MSA was merged with the target Fzo1 sequence with and 
without its first 100 N-terminal residues using M-Coffee (Supplementary Figs 1–4).
The T-Coffee method was used to align protein sequences from all the mitofusins belonging to the FZO1 
family listed in Supplementary Table 1 that were used in this study.
Structure prediction and model assessment. The secondary structure of Fzo1 was predicted from its sequence 
using the following algorithms: CONCORD52; PSIPRED (v 3.3)53; PSSpred54; and PORTER55. The LigPlot+ pro-
gram56 was used to inspect the homologous residues in the target and template that contact the GDP substrate 
using a donor-acceptor distance of 3.5 Å. The PCOILS v1.0.1 algorithm57 was used to predict heptad periodicity in 
Fzo1 and BDLP. Disordered residues in the target sequence were investigated using the predictor DISOPRED325.
Transmembrane domain. The BDLP template used for modelling Fzo1 possesses a hydrophobic region (res 
572–606, Supplementary Fig. 8) that mediates lipid binding but is not a TM domain16. As a result, the predicted 
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TM helices of Fzo1 (Supplementary Table 11) do not match in the final target-template alignment after refine-
ment (Supplementary Fig. 11). For this reason, the ab initio prediction of the helix dimer structure was crucial in 
the modelling process.
The location of the TM segments was identified using the predictors MEMSAT-SVM58, OCTOPUS59 
and TMpred60 (Supplementary Table 11). Ab initio modelling of the TM segments was performed using the 
PREDDIMER server27, and the best model was selected according to the proposed ranking score (FSCOR 3.113).
Strategy used to model the Fzo1-GDP complex. We manually refined the target-template alignment 
described above to avoid fragmenting the secondary structure elements. In particular, we modified the alignment 
to open a gap of 21 positions within the predicted TM helices of Fzo1. This modification enabled us to recon-
stitute the predicted fold for the C-terminal fragment (res 826–855) that was previously shown to be required 
for mitochondrial respiration34, but was unstructured and located outside the template in the initial alignment. 
Consistently, this modification positioned the residue L819, which induces a severe loss of function (LOF) when 
mutated to proline11, from a nearby unstructured region precisely within the putative hinge thought to enable 
the GTPase domain-dependent rearrangements. Moreover, consistent with the crystal structure of human Mfn1, 
this C-terminal fragment may participate in stabilizing the identified four-helix bundle18, 19. Finally, guided by the 
secondary structure predictors, small adjustments were made to restore helices that were disrupted by insertions 
and deletions (indels).
We combined three different templates to model the Fzo1 structure. The TM segments (res 706–726 and 
737–757) were based on the ab initio model, the pentapeptide 216–220, which was unresolved in structure 2J68, 
was modelled on residues 98–102 from structure 2J69 (3.0 Å16), and the remainder of the protein followed struc-
ture 2J68. One hundred models were generated using the MODELLER program (v 9.15)61. The GDP nucleotide 
coordinates from structure 2J68 were included during the modelling procedure. During modelling, harmonic 
restraints were imposed on donor-acceptor distances, based on the LigPlot+ analysis of protein-nucleotide inter-
actions in template 2J68. Moreover, we imposed canonical α-helix conformations for residues 101–123, 299–304, 
426–433, 548–553, 700–726, 737–757 and 847–855, as well as β-strand conformations for residues 234–241 and 
281–283.
We performed loop refinement of the intermembrane loop (res 727–736) and we applied the loop modelling 
routine of MODELLER62 resulting in fewer Ramachandran outliers. We ranked solutions according to the dis-
crete optimized protein energy (DOPE) method63.
The Dunbrack rotamer library64 implemented in University of California, San Francisco (UCSF) Chimera24 
was used to change the rotamers of the Lys727, Lys735 and Lys736 residues, which are located within the inter-
membrane loop, by orienting the charged side-chains towards water to stabilize the TM domain during the MD 
simulation. Similarly, the rotamer of residue Ile753 was changed to increase TM helix packing. The PROPKA 
method65 (v 3.00) implemented in the automated PDB2PQR pipeline66 (v 2.0.0) was used to assign protonation 
states at pH 7. A double protonation was predicted for the His240 residue. The lipid-buried Lys716 residue is 
conserved in half of the genes belonging to the FZO1 family (Supplementary Table 1 and Supplementary Fig. 15). 
According to recent data, lysine residues are titrated in a membrane environment, suggesting that changes in the 
ionization state may regulate membrane-protein function67. Therefore, the protonation state of the lipid-buried 
Lys716 was manually set to a neutral amine. The stereochemical quality was assessed using the MolProbity 
server22 and PROCHECK23. The model obtained was then oriented with respect to the lipid bilayer using the PPM 
server68. These coordinates were subsequently manually adjusted by a 6° rotation around the x axis and a transla-
tion of −1.5 Å along the z axis to improve the lipid-packing around the Fzo1 TM domain, and empty spaces in the 
bilayer were avoided during model building using the CHARMM-GUI pipeline (see below).
Simulation setup and equilibration. The GROMACS 5.0.4 program was used to perform the MD 
simulations69. The simulation system was assembled using the CHARMM-GUI Membrane Builder70 with the 
CHARMM36 force field71. In order to mimic the mitochondrial outer membrane composition, the protein model 
was embedded in a 1:1 mixed lipid bilayer composed of 156 molecules of palmitoyl-oleoyl-phosphatidylcholine 
(POPC) and 156 molecules of palmitoyl-oleoyl-phosphatidylethanolamine (POPE). The solvent is composed 
of a 150 mM KCl solution with 36,919 TIP3P water molecules72. One magnesium ion was manually positioned 
between the α and β GDP phosphates, consistent with crystal structures 2X2E, 3T34, 3W6P and 5CA9 for human 
dynamin 141, dynamin-related protein 1 A from Arabidopsis thaliana73, human dynamin-1-like protein74 and 
Sey1p from Candida albicans75, respectively. Two K+ counterions were subsequently added to neutralize the sys-
tem. Supplementary Table 12 reports the composition of the simulation system. Before running the simulations, 
the system was subjected to 8000 steps of energy minimization. Afterwards, the structure was thermalized at 
310 K for 200 ps using the NVT ensemble, with a time step of 2 fs and position restraints of 1000 kJ·mol−1·nm−2 
on all protein heavy atoms. Subsequently, the same restraint settings were applied in 10 ns simulations using the 
NPT ensemble to allow the lipids to relax. The optimized and relaxed system was further equilibrated for a total 
of 250 ns using the NPT ensemble by combining position restraints on side-chains and backbone atoms, which 
were gradually relaxed from 1000 to 5 kJ·mol−1·nm−2 in seven successive steps. Simultaneously, we maintained 
distance restraints of 1000 kJ·mol−1·nm−2 for the previously identified GDP homologous hydrogen bond network 
(see above). After 250 ns of equilibration, three replicas of the same system (Fzo1.I, Fzo1.II and Fzo1.III) were 
simulated for a total of 500 ns with an integration time step of 2 fs in the NPT ensemble under periodic boundary 
conditions. Long-range electrostatics were managed using the particle-mesh Ewald (PME) method76. All bond 
lengths were constrained using the LINCS algorithm77. Global translational and rotational motions were removed 
every 100 steps. Atomic positions were saved every 50 ps, and the first 100 ns were not used for the analysis.
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Trajectory analysis and molecular graphics. Root mean-square deviation (RMSD) and fluctuation 
(RMSF) analyses were performed using tools from the GROMACS package (g_rmsf and g_rmsf, respectively). A 
refined RMSD value was computed by omitting residues that fulfilled one or more of the following criteria: when 
a residue possesses a large RMSF value, is less conserved, unstructured, predicted to be disordered, hypothesized 
to be implicated in putative conformational change (e.g., hinge regions), unresolved in the template, and involved 
in a progressive loss of folding.
Secondary structure elements were identified using the do_dssp tool implemented in GROMACS based on 
the DSSP method78. Hydrogen bonds and salt bridges were identified using g_hbond from GROMACS and VMD 
1.9.279 (http://www.ks.uiuc.edu/Research/vmd/), respectively. Contacts within a distance cut-off of 3.5 Å (and up 
to 30 degree off-axis angle) and 6.5 Å were considered for H-bonds and salt bridges, respectively, to assess these 
interactions. Other analyses were conducted using in-house programs. When not otherwise specified, the persis-
tence means how much the considered event occurs during the simulation time, expressed as a percentage over 
the number of frames. The cluster analysis was performed using g_cluster from GROMACS with the GROMOS 
method80, with a cut-off of 0.25 Å. Molecular graphics were generated with the VMD 1.9.279 (http://www.ks.uiuc.
edu/Research/vmd/) and UCSF Chimera 1.924 packages. Data were plotted using Grace (http://plasma-gate.weiz-
mann.ac.il/Grace/).
Plasmids, yeast strains and growth conditions. FZO1 mutant plasmids are listed in Supplementary 
Table 13. Plasmids MC377 to MC382, MC396 and MC397 were synthesized by GeneCust (Ellange, Luxembourg). 
A QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, California, USA) 
was used to generate plasmids MC400 and MC406 to MC408. Mutagenic primers were designed based on the 
MC250 plasmid sequence with the web-based QuikChange Primer Design Program available online at www.
agilent.com/genomics/qcpd.
Yeast strains are listed in Supplementary Table 14. Standard methods were used for growth, transformation 
and genetic manipulation of S. cerevisiae. Minimal synthetic media [Difco yeast nitrogen base (Voigt Global 
Distribution, Inc., Lawrence, Kansas, USA), and drop-out solution] supplemented with 2% dextrose (SD) or 2% 
glycerol (SG) were prepared as previously described81.
Strains lacking FZO1 lose their mitochondrial DNA because of decreased mitochondrial fusion efficiency9, 26. 
Consequently, a plasmid-shuffle strategy was used as a reliable analysis of fzo1 mutants in vivo. The FZO1 shuffle 
strain MCY571 (fzo1Δ strain covered by an FZO1 shuffling plasmid) was employed. MDM30 was chromosom-
ally deleted in the FZO1 shuffle strain using a previously described method82 to generate the mdm30Δ strain 
(MCY585).
Shuffle strains were transformed with the plasmids shown in Supplementary Table 13 and plated on SD selec-
tive media lacking uracil and tryptophan. Ten colonies were systematically isolated on SD selective media and 
replica-plated on 5′-fluoroorotic acid (5′-FOA) plates. Strains grown on 5′-FOA plates and cured from the FZO1 
shuffling plasmid were in turn replica-plated on SD and SG selective plates lacking tryptophan. The glycerol 
growth phenotypes of strains cured from the shuffling plasmids were reproducibly observed in 100% of the clones 
tested after 1 to 3 days of growth at 30 °C. Representative clones were subsequently used for spot assays and the 
preparation of protein extracts.
Spot assays. Cultures grown overnight in SD selective media lacking tryptophan were pelleted, resuspended 
at an optical density at 600 nm (OD600) of 1, and serially diluted (1:10) five times in water. Three microliters of 
the dilutions were spotted onto SD- and SG-selective plates and grown for 2 to 4 days (dextrose) or 3 to 6 days 
(glycerol) at 23 °C, 30 °C or 37 °C.
Protein extracts and immunoblotting. Cells grown in SD-selective media lacking tryptophan were 
collected during the exponential growth phase (OD600 = 0.5–1). Total protein extracts were prepared using the 
NaOH/trichloroacetic acid (TCA) lysis technique83. Proteins were separated on 8% SDS-PAGE gels and trans-
ferred to nitrocellulose membranes (AmershamTM HybondTM-ECL; GE Healthcare, Little Chalfont, United 
Kingdom). The primary antibodies used for immunoblotting were monoclonal anti-Pgk1 (Abcam, Cambridge, 
United Kingdom), monoclonal anti-myc (9E10), and polyclonal anti-Fzo1 (generated by GeneCust). Primary 
antibodies were detected using horseradish peroxidase-conjugated secondary anti-mouse or anti-rabbit anti-
bodies (HRP, Sigma-Aldrich, Saint-Louis, Missouri, USA), followed by incubation with a ClarityTM Western 
Kit (Bio-Rad, Hercules, California, USA). Images of the immunoblots were acquired using a Gel DocTM XR+ 
(Bio-Rad) and analysed using the Image Lab 3.0.1 software (Bio-Rad). The anti-Fzo1 is not sensitive enough to 
detect ubiquitylated species of the mitofusin. For this reason, the ubiquitylation status of Fzo1 was analyzed using 
FZO1-13MYC strains and immunoblotting with anti-myc.
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